Peritoneal tuberculosis simulating advanced ovarian carcinoma: is clinical impression sufficient to administer neoadjuvant chemotherapy for advanced ovarian cancer?. (1st January 2006)

• Record Type: Journal Article
• Authors: Gurbuz, A.; Karateke, A.; Kabaca, C.; Kir, G.; Cetingoz, E.
• Is Part Of: International journal of gynecological cancer. Volume 16(2006)Supplement 1
• Page Start: 307
• Page End: 312
• Publication Date: 2006-01-01
• Subjects: CA125 -- chemotherapy -- neoadjuvant -- ovarian cancer -- peritoneal tuberculosis; Generative organs, Female -- Cancer -- Periodicals; 616.99465
• DOI: 10.1136/ijgc-00009577-200602001-00051
• Languages: English
• ISSNs: 1048-891X

Abstract

Abstract : Peritoneal tuberculosis mimics advanced ovarian cancer because of the similarities in clinical signs and symptoms such as ascites, pelvic and abdominal pain and mass, and elevation of serum CA125 level. We have presented four cases of peritoneal tuberculosis that underwent exploratory laparotomy for suspected advanced ovarian cancer during a 3-year period. Definitive diagnosis of tuberculosis was performed at laparotomy in all the cases. The frozen-section analysis seems to be the gold standard in the differential diagnosis. In view of these data, clinical diagnosis of advanced ovarian cancer is not sufficient for administering neoadjuvant chemotherapy. Cytologic or pathologic findings must be consistent with ovarian cancer for candidates who are being considered for neoadjuvant chemotherapy.